InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
67%
T+90 mean return
+23.1%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Nicholson Nur, Chief Technical Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 21 disclosures have been recorded. Split: 0 buy · 7 sells. Total volume traded: €886k. History available since 21 January 2022. The latest transaction was disclosed on 29 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations21 total
116,338 sharesCommon StockSEC:0001193125-26-224604:0
116,338 sharesCommon StockSEC:0001193125-26-224604
825 shares@ US$29.52361.8% of flowCommon StockSEC:0001127602-25-002383:0
3,948 shares@ US$30.42559.0% of flowCommon StockSEC:0001127602-25-001841:0
2,145 shares@ US$29.95824.9% of flowCommon StockSEC:0001127602-25-001625:0
36,426 shares0Common StockSEC:0001127602-25-001625:1
2,632 shares@ US$28.70215.8% of flowCommon StockSEC:0001127602-25-001201:0
7,768 shares@ US$57.30731.8% of flowCommon StockSEC:0001127602-24-010127:0
835 shares@ US$64.13823.9% of flowCommon StockSEC:0001127602-24-002746:0
2,593 shares@ US$64.99612.1% of flowCommon StockSEC:0001127602-24-001953:0
19,508 shares0Common StockSEC:0001127602-24-001437:0
9,719 shares@ US$29.7668.5% of flowCommon StockSEC:0001127602-23-024445:0
9,886 shares0Common StockSEC:0000899243-23-005786:0
551 shares@ US$52.772.1% of flowCommon StockSEC:0001127602-23-002687:0
2,034 shares@ US$52.057.6% of flowCommon StockSEC:0001127602-23-002133:0
1,875 shares0Common StockSEC:0001127602-23-001499:0
22,580 shares0Common StockSEC:0001127602-23-001499:1
650 shares@ US$38.590.0004% mcap50.0% of flowCommon StockSEC:0001127602-22-002812:0
650 shares@ US$38.590.0004% mcap100.0% of flowCommon StockSEC:0001127602-22-002812
26,051 shares0Common StockSEC:0001127602-22-002062
26,051 shares0Common StockSEC:0001127602-22-002062:0
21 of 21 declarations
About Nicholson Nur
Nicholson Nur is the Chief Technical Officer of Apellis Pharmaceuticals, Inc.
